Tokyo, July 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062355) titled 'study examining whether a motion-analysis app can accurately measure leg movement during the forward lunge' on July 27.
Study Type:
Observational
Primary Sponsor:
Institute - Kio univercity
Condition:
Condition - Healthy volunteers (no target disease)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to examine the validity of joint angle measurements obtained by the video-based motion analysis application SPLYZA Motion during forward lunge movement in healthy adults, by comparing hip, knee, and ankle joint angles against a laboratory-based three-dimensional motion capture system (VICON) as the reference standard.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - Healthy adults who can safely perform the forward lunge task and who provide informed consent
Key exclusion criteria - Individuals with a history of lower limb injury within the past six months; orthopedic disorders of the trunk or lower limbs, or a history of fracture or surgery of the hip, knee, or ankle joints; neurological or muscular diseases, peripheral neuropathy, or sensory impairment affecting daily living or sports activities; or those unable to perform the task movement.
Target Size - 30
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 07 Month 27 Day
Anticipated trial start date - 2026 Year 08 Month 01 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071366
Disclaimer: Curated by HT Syndication.
